INTRODUCTION
; 80: 1713-1720. Cancer is not a single disease, but act as agroup of diseases which characterized by uncontrolled, rapid, and pathological proliferation of abnormal cells. cancer is an important cause of death after cardiovascular disorders around the world although recent advances studies in cancer therapy (1) .
Chemotherapeutic agents are A challenge in the fight against cancer. Another challenge for chemotherapy is lack of selectivity. as anticancer drugs destroy normal cells as well as cancer cells and may affected adversely. New antineoplastic agents are developed continously to be selectively destroy tumor cells or at least limit their proliferation. (2)
Pyrazolines are important nitrogen containing five membered heterocyclic bioorganic molecules These compounds occured in nature as alkaloids, vitamins, and pigment sand as plant and animal cell contents (3) . Activity of pyrazolines differed due to avariety of functional groups as substituents and widely used due to their various biological and pharmacological activities in the current decades (4) .pyrazolines are not only useful in treatment of various cancer types ,but also some of them act as cancer chemopreventive agents. (5) C5 atom deviated from planar system of the other four atoms of the heterocyclic ring (6) . 2-pyrazoline is insoluble in water but soluble in propylene glycol or DMSO(dimethyl sulfoxide) because of its lipophilic character (7) . Pyrazoline derivatives are Intra-molecular Charge Transfer (ICT) compounds, an intramolecular conjugated charge transfer process reported to exist it in the excited state. In the conjugated part (-N1-N2-C3-) of the ring, the nitrogen atom at the 1-position is electron donating and the carbon atom at the 3position has withdrawing activity, but The carbon atoms at 4-and 5-positions do not conjugate with the above conjugated part (8) . 2-Pyrazolines is the most pyrazoline type that used widely (9) .The popular procedure is based on the reaction of α,β un saturated aldehydes and ketones with hydrazines (10) .
The combination of the hydrazono group with other functional groups leads pyrazoline compounds to be unparalleled in physical and chemical properties. Pyrazoline derivatives display various biological activities such as antitumor, antifungal, antiviral, anti-parasitic ,anti-inflammatory, analgesic , antimycobacterial ,anticancer, antibacterial, insecticidal, antinociceptive, hypotensive ,anti-depressant, photoluminiscence, antitubercular, anti-amoebic, amine oxidase inhibitory and antioxidant properties (11) . In our study antioxidant enzyme observed as they are native to normal tissue or they associated with changes in metabolism and that are unique to cancer tissue. Nitric oxide (NO) is the simplest active molecule which synthesized from L-arginine amino acid by the enzyme nitric oxide synthase (NOS). It is the only endogenous molecule acts as a mediator, a hormone ,a reactive Oxygen species (ROS), neurotransmitter, cytoprotective and cytotoxic molecule (12) . A decrease in NO production stimulates oxidative phosphorylation and increases peripheral oxygen uptake (13) that caused by lipid peroxidation, nitrosylation of molecules , in activation of sodium channels, and redox reaction with metals such as iron and copper (14) Arginase (Larginine amidino hydrolase) is homotrimeric metalloenzyme that catalyzes the hydrolysis of L-arginine, execution urea for ammonia elimination, and L-ornithine (a non-protein amino acid), for biosynthetic pathways (15) there are two forms of arginase. 1) Arginase I is cytosolic ,it almost found in the liver, responsible for ammonia detoxification as urea,2)Arginase II, is isoenzyme which involved in the production of ornithine as a precursor essential for cellular growth (16) . Polyamines are important for cell proliferation as the increased level of ornithine, due to the elevated arginase activity, refered to the development of carcinogenesis (17) . Ahigh arginase level in breast cancer was detected to be released into serum . Arginase enzyme is a useful biological marker in breast cancer and act as an indicator of breast cancer progression, the more advanced the breast cancer, the higher the serum level of arginase enzyme activity, The activity levels of arginase in malignant breast tissues were reported by Porembska et al. (18) ; Straus et al. (19) and Erbas etal. (20) .The relationship between the NO and arginase involves not only the use of the same substrate (21) ; (22) but also, In healthy individuals, sufficient arginase activity can limit the use of arginine for the synthesis of NO (23) (24) . This work aims to investigate the antitumor and antioxidant activities of some pyrazoline derivatives.
Materials and Methods: Synthesis of Pyrazolines
Pyrazoline derivatives were synthesized (25) . As The chalcones were condensed with phenyl hydrazine in absolute ethanol in the presence of pyridine at reflux temperature (2 to 6 h). The solvent was completely evaporated and the residue was poured into ice cold water, which resulted in the formation of the corresponding 2-pyrazolines. Reaction completion was identified by thin layer chromatography (TLC) using silica gel-G. After completion of the reaction, the reaction mixture was poured into crushed ice with constant stirring. The separated solid was filtered and dried. It was purified by column chromatography on silica gel, using ethyl acetate and hexane mixture as the mobile phase. After purification the 2pyrazolines were obtained as light or bright colored powders.
Elucidation of Chemical structure of Pyrazoline derivatives:
methyl-4-(o-methyl phenyl (azo)hydrazono)-2-pyrazoline -5-one, And Compound (5): 1-Phenyl-3-methyl-4-(mmethoxy phenyl(azo)hydrazono)-2pyrazoline-5-one, were identified using IR according to Laurence and Christopher method (26) .The structure of the synthesized compounds illustrated in fig. (1, 2,3,4,and 5) . Animals Adult female Swiss albino mice weigh (20-25 g) were purchased Abo Rawash culture -Giza used throughout this study. The animals were housed in steel mesh cages (animal house, faculty of Science, Zagazig University) and maintained in controlled environment of temperature, humidity, light, and fed on a commercial standard diet and tap water ad libitum. Ehrlich ascites carcinoma (EAC) EAC cells were initially supplied from the National Cancer Institute, Cairo, Egypt (only for the first transplantation), and maintained in female Swiss albino mice through serial intraperitoneal (I.P.) as the dose was 0.064 ml of EAC complete till 0.3ml with saline that containing (2.5×10 6 cells) inoculation at 8 or 10 day intervals in our laboratory in an ascites form.
Toxicity Study
Determination median lethal dose (LD 50) of the synthesized compounds: Approximate LD50 of albino Swiss mice was determined according to method Meier and Theakston, (1986) (27) . The acute toxicity was estimated by intraperitoneal injection of the compounds (1, 2, 3, 4, and 5) to determine the median lethal dose (LD50) of each compound.
Experimental design
Female Swiss albino mice were divided into the following groups (10 mice/ each group) as follows: Group (I): Negative Control: mice injected I.P. with sterile saline for 10 days. Group (II): Positive Control (EAC bearing group): mice injected I.P. with EAC cells,(2.5×10 6 cells /0.3 ml per mouse) once. Group (III) treated group with compound 1: was subdivided into the following three subgroups: (a): Therapeutic Group: (EAC+ compound 1) : mice were injected I.P. with compound 1 (200mg/Kg) after EAC injection (2.5×10 6 cells /mouse), followed by I.P. injection of compound 1 at 3, 5, 7, 9 days of EAC injection for 10 days. (b): Preventive Group: (compound 1 + EAC): mice were injected I.P. with compound 1 (200 mg/Kg) day before EAC injection (2×10 6 cells/mouse), followed by I.P. injection of compound 1 at 3, 5, 7, 9 days of EAC injection for10 days.(c):Positive Drug 1 Group:(compound 1): mice were injected I.P. with compound 1 (200 mg/Kg) day after day for 10 days. Group (IV) compound (2) treated group: was subdivided into the following three subgroups: (a): Therapeutic Group: (EAC + compound 2): mice were injected I.P. with compound 2 (200 mg/Kg) after EAC injection (2.5×10 6 cells/ mouse), followed by I.P. injection of compound 2 at 3, 5, 7, 9 days of EAC injection for 10 days. (b): Preventive Group: (compound 2+ EAC): mice were injected I.P. with compound 2 (200 mg/Kg) day before EAC injection (2.5×10 6 cells/mouse), followed by I.P. injection of compound 2 at 3, 5, 7, 9 days of EAC injection for 10 days. (c): Positive Drug 2 Group: (compound 2): mice were injected I.P. with compound 2 (200 mg/Kg) day after day for 10 days. Group (V) compound (3) treated group: mice were injected I.P. with compound 3 was subdivided into the following three subgroups: (a): Therapeutic Group: (EAC + compound 3): mice were injected I.P. with compound 3 (200 mg /Kg) after EAC injection (2.5×10 6 cells / mouse), followed by I.P. injection of compound 3 at 3, 5, 7, 9 days of EAC injection for 10 days. (b): Preventive Group: (compound 3+ EAC) mice were injected I.P. with compound 3 (200 mg/Kg) day before EAC injection (2.5×10 6 cells/mouse), followed by I.P. injection of compound 3 at 3, 5, 7, 9 days of EAC injection for 10 days. (c): Positive Drug 3 Group: (compound 3): mice were injected I.P. with compound 2 (200 mg/Kg) day after day for 10 days. Group (VI) compound (4) treated group: was subdivided into the following three subgroups: (a) Therapeutic Group: (EAC + compound 4): mice were injected I.P. with compound 4 (200 mg/Kg) after EAC injection (2.5×10 6 cells/mouse), followed by I.P. injection of compound 4 at 3, 5, 7, 9 days of EAC injection for 10 days. (b) Preventive Group: (compound 4+ EAC) mice were injected I.P. with compound 4 (200 mg/Kg) day before EAC injection (2.5×10 6 cells/mouse), followed by I.P. injection of compound 4 at 3, 5, 7, 9 days of EAC injection for 10 days. (c): Positive Drug 4 Group: (compound 4): mice were injected I.P. with compound 4 (200 mg/Kg) day after day for 10 days. Group (VII) compound (5) treated group: was subdivided into the following three subgroups:(a) Therapeutic Group: (EAC + compound 5): mice were injected I.P. with compound 5 (200 mg/Kg) after EAC injection (2.5×10 6 cells/mouse), followed by I.P. injection of compound 5 at 3, 5, 7, 9 days of EAC injection for 10 days; (b) Preventive Group: (compound 5+ EAC): mice were injected I.P. with compound 5 (200 mg/Kg) day before EAC injection (2.5×10 6 cells/mouse), followed by I.P. injection of compound 5 at 3, 5, 7, 9 days of EAC injection for 10 days. (c): Positive Drug 5 Group: (compound 5) mice were injected I.P. with compound 5 (200 mg/Kg) day after day for 10 days.
Collection of Blood Samples and EAC Cells:
at the end of the experiment, the blood samples were collected from the retro-orbital venous plexus under light ether anesthesia. Plasma prepared and stored at -20 0 C until biochemical analysis. EAC cells were harvest from each mouse in centrifuge tube containing heparinized saline. Note the volume of ascetic fluid in each mouse in each group. Each sample of cells were undergoes counting and viability of EAC cells in each group.
Viability and Counting of EAC cells:
The viability of EAC cells was determined by the Trypan Blue Exclusion Method described by Mcliman etal (1957) (28) .
Effect of compounds (1, 2, 3, 4, and 5) on life span prolongation:
Life span calculation was carried out according to the method described by Mazumdar etal (1997) (29) . Antioxidant assays: Malondialdehyde (MDA) determined according to methods of (Satoh, 1978) (30) , Nitric Oxide (NO) levels according to Montgomery and Dymock (1961) (31), , Superoxide dismutase (SOD) according to Nishikimi etal ,(1972) (32) ,Total Antioxidant Capacity (TAC) according to Koracevic etal.,(2010) (33) and
Arginase activities according to Marsch, etal.,(1965). (34) Statistical Analysis: all statistical analyses were done by a statistical for social science package "SPSS" 14.0 for Microsoft Windows, SPSS Inc. Levesque (2007) (35) and considered statistically significant at a two sided P < 0.05.
Results Toxicity Study
Studies carried out for determination of the median lethal dose are important to help us to assess the limit dose recommended, we use procedure described by to calculate the (LD 50), Doses for all compounds were being safe until 400mg/kg;as the selective dose for all compounds were 200 mg/kg, as reported by Kalpana D. (2014) (36) . Infrared spectral study: Fig. (1, 2, 3 , 4 and 5), illustrated IR spectra of compounds (1, 2, 3, 4 and 5; respectively). In compound (1) the absorption bands at 1252, 3447 and1496 for OCH 3 , NH and N=N respectively. N=C, C-O and C=O groups give bands at 2366, 1152 and 1655. C-H aromatic and CH 3 aliphatic appear at 3030 and 2922. The characteristic bands of compound (1) were still present in compounds (2 to 5) except the disappear of band character of OCH 3 at 1252 ,and showed three new peaks at 1556,1072,1047 attributed to NO 2 , Cl in meta position and Cl at ortho positions respectively.
Viability and life span prolongation
The mean values of EAC volume and count were found to be 5.8±0. 24 The mean life span in the positive control group was found to be 16 days. cpd1, cpd2, cpd3, cpd4 and cpd5 treated groups showed a significant increase in the life span prolongation to 23 days by 44% (T/C ratio= 144%), 29 days by 81% (T/C ratio= 181%), 21 days by 31% (T/ C ratio = 131%), 25 days by 56% (T/C ratio= 156%) and 26 days by 63% ( compounds (1, 2, 3, 4, and 5) synthesized compounds (1, 2, 3, 4, and 5 compounds (1, 2, 3, 4, and 5) . pyrazolines are used as constituent part of a molecule in organic synthesis (55) ,as optical bright ening agents for textiles, paper, and fabrics, and as a hole-conveying medium in photo conductive materials (56) .All the pyrazolines found to be free from toxicity as well as toxic symptoms even at high dose of 1000mg/kg body weight and hence they were considered safe, The acute toxicity test conducted on Swiss mice shown that all the synthesized compounds were free of toxic symptoms even at concentration of 1000mg/kg body weight andwere considered safe compounds Cornel et al., (2015) (57) . On a hand, our tested compounds (Pyrazoline derivatives) reduced the volume and count of cancer cells, and increased the life span of mice. On the other hand, these compounds have anti-oxidant activity by affecting on antioxidant enzymes , Compound 2 [1-Phenyl-3-methyl-4-(m-chlorophenyl (azo)hydrazono)-2-pyrazoline-5-one] showed the greatest anti-tumor and anti-oxidant activities than other tested compounds. Compounds with electron withdrawing groups (halogens) on the aromatic ring favor antitumor, analgesic, and anti-inflammatory activities (58) . Also, 1, 2-pyrazoline nitrogen mustards with a phenyl and hydroxyl phenyl group at second and fifth position was found to be effective in the inhibition of cancer growth (59) .Pyrazoline compounds have a significant effect on enzymes that are native to normal tissue or those that could be associated with changes in metabolism and that are unique to cancer tissue. One of these enzymes is arginase. Arginase activity caused by the proliferation of tumor cells. Arginase and NO have very different effect on the growth of nearby tumor cells depending on which pathway is controlling . there is a significant increase in arginase activity and serum levels of NO in patients with breast cancer and these parameters used as a useful biological marker in breast cancer and as an indicator of breast cancer progression (60) .These compounds have antioxidant activity, this is due to the substitution in the aromatic ring system with halogens like chlorine can increase the antioxidant potency, as chlorine atom has lone pair electron as well as its electronegative power enhanced the formation and subsequent stabilization of the nitrogen-ring radical through intervening aromatic system property, it might have enhanced the power to absorb free radicals, especially reactive oxygen and reactive nitrogen species (ROS and RNS) (61) . Erhan Palaska et al., (62) reported that 4-chloro and 4-methoxy substituents on the phenyl ring at position 3 of the pyrazoline ring (Meta position) increased the antitumor activity; the replacement of these groups by Nitro and methyl substituents decreased activity in mice. In general, (substitution by a halogen atom particularly, a chlorine atom) in the 'meta' position of the phenyl ring led to a better anti-tumor effect than that observed in the absence of any substituent (63) . These findings were in a line with many authors, Alka et al., (64) who, reported that Pyrazoline ring containing compounds with alkylating groups can act as antitumor agents, further alkoxy groups and halogen atoms as substituent groups on the aromatic ring of the molecules shown significant anti-cancerous activity. Nagwa and Nadia (2015) (65) : Who reported that synthesizedpyrazoline had antimicrobial activity. These compounds as molecular structure that is responsible for aparticular biological or pharma-cological interaction that it undergoes ,with lipophilic properties such as chloro and bromo substituents offered the greatest antitumor activities.Also,Compounds with a methyl substituent at the para position of the phenyl ring showed good activity; while compounds with a nitro substituent at the para and meta positions, respectively ,exhibited moderate activity. Rajendra,etal., (2005) (66) reported the compounds possessing electron-releasing groups such as methoxy, on both the aromatic rings at positions 3 and 5 of pyrazolines, considerably enhanced the antitumor activity when compared to the pyrazolines having no substituents on the phenyl rings .
Conclusion:
Pyrazoline derivatives have anticancer and anti-oxidant activities. Compound (2) 1-Phenyl-3 methyl-4-(mchlorophenyl(azo)hydrazono)-2-pyrazoline -5-one has a significant effect more than other synthesized compounds, as its halogen substitution in the meta position, which act as electron withdrawing groups on the aromatic ring chlorine atom has lone pair electron as well as its electronegative power enhanced the formation and posterior stabilization of the nitrogen-ring radical through interfere aromatic system property, it increased the power to absorb free radicals, especially reactive oxygen and reactive nitrogen species ,this favor antitumor, antioxidant ,analgesic, and anti-inflammatory activities. Effect of compounds (1, 2, 3, 4 
, and 5) on volume and viability of EAC cell (×10 6 cell/ ml): in studied groups:
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